Cutaneous Oncology News

The integration of convolutional neural networks into dermatology practices, especially those with fewer than 5 years of experience, may increase diagnostic accuracy of skin cancer, according to a prospective study.

Although skin cancer is the most common type of cancer worldwide, melanoma — the deadliest form of skin cancer — has a 5-year survival rate of 99% when detected early.

Wide local excision and Mohs micrographic surgery exhibited no difference in survival outcomes among patients with Merkel cell carcinoma, according to a study.

In the treatment of melanoma that is close to critical structures, narrow excision saw similar rates of mortality and recurrence compared with wide excision, but fewer rates of reconstructive surgery, according to a study.

Patients treated with hydrochlorothiazide for hypertension may face an increased risk for certain skin cancers with longer duration of use, according to a study.

Concurrent intrathecal and IV nivolumab appeared safe and showed potential efficacy among a small cohort of patients with melanoma and leptomeningeal disease, according to results of a phase 1/1b study published in Nature Medicine.

Today is Melanoma Monday.

Psoriasis patients taking methotrexate are nearly three times as likely to develop nonmelanoma skin cancer compared with those not taking the drug, according to a study.

The U.S. Preventive Services Task Force has concluded there is not enough evidence to recommend skin cancer screenings by primary care physicians in adolescents and adults without symptoms.

The addition of an mRNA-based cancer vaccine to pembrolizumab extended RFS among patients with resected high-risk melanoma, according to study results presented at American Association for Cancer Research Annual Meeting.